OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA

NCT01694758 · clinicaltrials.gov ↗
COMPLETED
Status
733
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca